These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 19657984

  • 21. Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease.
    Nazari H, Rao NA.
    Br J Ophthalmol; 2012 Nov; 96(11):1410-4. PubMed ID: 22942161
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease.
    Maruko I, Iida T, Sugano Y, Oyamada H, Sekiryu T, Fujiwara T, Spaide RF.
    Retina; 2011 Mar; 31(3):510-7. PubMed ID: 20948460
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease.
    Read RW, Yu F, Accorinti M, Bodaghi B, Chee SP, Fardeau C, Goto H, Holland GN, Kawashima H, Kojima E, Lehoang P, Lemaitre C, Okada AA, Pivetti-Pezzi P, Secchi A, See RF, Tabbara KF, Usui M, Rao NA.
    Am J Ophthalmol; 2006 Jul; 142(1):119-24. PubMed ID: 16815259
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.
    Attia S, Khochtali S, Kahloun R, Ammous D, Jelliti B, Ben Yahia S, Zaouali S, Khairallah M.
    Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Infliximab therapy for 2 patients with Vogt-Koyanagi-Harada syndrome.
    Wang Y, Gaudio PA.
    Ocul Immunol Inflamm; 2008 Feb; 16(4):167-71. PubMed ID: 18716952
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Vogt-Koyanagi-Harada syndrome in a case of multiple sclerosis.
    Montero JA, Sanchis ME, Fernandez-Munoz M.
    J Neuroophthalmol; 2007 Mar; 27(1):36-40. PubMed ID: 17414871
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
    Yang P, Sun M.
    Cornea; 2011 Dec; 30(12):1336-40. PubMed ID: 21934492
    [Abstract] [Full Text] [Related]

  • 38. Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease.
    Zhao C, Dong F, Gao F, Liu X, Pei M, Jia S, Zhang M.
    BMC Ophthalmol; 2018 Jan 15; 18(1):6. PubMed ID: 29334924
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.